Treat Gut
Precision microbiota transplant therapy for intestinal microecology, offering comprehensive solutions for human microecological health.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
* | CNY100m | Early VC | |
| Total Funding | 000k | ||
Related Content
Founded in 2016 by Xiao Chuanxing, TreatGut is a biopharmaceutical company specializing in intestinal microecology.
The company focuses on developing and providing precision microbiota transplant therapy. This therapy is designed to offer comprehensive solutions for human microecological health. TreatGut has an integrated business model that includes research and development, manufacturing, sales, and service, enabling it to control the entire value chain from innovation to market delivery.
TreatGut's core offering is a comprehensive solution for precise bacterial transplantation treatment. This involves the transplantation of functional flora from healthy donors to patients to rebuild a healthy intestinal microecology. The company serves clients in the healthcare sector, providing them with advanced therapies for various health issues related to intestinal microecology.
Keywords: biopharmaceutical, microecology, microbiota, transplant therapy, intestinal health, bacterial transplantation, healthcare solutions, life sciences, biotechnology, gut health